Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
28 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-302540604.html
20 Aug 2025
// BIOSPACE
https://www.biospace.com/fda/regenxbios-hunter-syndrome-gene-therapy-hit-with-3-month-pdufa-delay
31 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/regenxbio-to-host-conference-call-on-august-7-to-discuss-second-quarter-2025-financial-results-and-operational-highlights-302518467.html
11 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/regenxbio-announces-publication-of-preclinical-results-demonstrating-functional-benefits-of-novel-microdystrophin-construct-in-rgx-202-investigational-gene-therapy-for-duchenne-muscular-dystrophy-302502606.html
05 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/regenxbio-reports-new-positive-functional-data-from-phase-iii-affinity-duchenne-trial-of-rgx-202-302473842.html
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-accepts-biologics-license-application-for-mucopolysaccharidosis-ii-treatment-302454515.html
ABOUT THIS PAGE